<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Mutations or deletions in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene p53 are among the commonest genetic changes found in human <z:hpo ids='HP_0002664'>neoplasms</z:hpo> including breast, lung and <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">bowel cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, p53 is most often mutated in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, with p53 mutations present in 30 to 40% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples and in 70% of cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To analyze the p53 gene alterations in child patients with B non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Descriptive study </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Tertiary <z:hpo ids='HP_0002664'>oncology</z:hpo> care center </plain></SENT>
<SENT sid="5" pm="."><plain>PARTICIPANTS: The study investigated 12 patients with childhood B non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>Screening for p53 mutations was done by polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) analysis of exon 5 to 8/9 of the gene </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Abnormal polymerase chain reaction-single strand conformational polymorphism migration pattern was observed in 4 patients (33.3%), one on exon 6 and three on exon 7 </plain></SENT>
<SENT sid="8" pm="."><plain>Positive cases included 2 patients who died from disease </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: These preliminary results suggest that p53 mutations are quite frequent in children with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and may play a role in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> genesis or disease progression </plain></SENT>
</text></document>